IDEXX LABORATORIES INC /DE
IDXXNasdaq · SIC 2835
$567.44
↓ -1.5%Jul 17 close · end-of-day
Price
1Y↑ +9.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$45.5B
Enterprise Value
$45.7B
P/E
41.8
P/S
10.2
P/B
29.2
EV/EBITDA
29.4
PEG
2.4
FCF Yield
2.4%
Dividend Yield
—
Revenue (TTM)
$4.4B
Net Income (TTM)
$1.1B
Free Cash Flow (TTM)
$1.1B
Gross Margin
62.1%
Operating Margin
31.6%
Net Margin
24.6%
ROE
70.4%
ROIC
62.3%
Debt / Equity
0.3
Net Cash
-$249.3M
Return 1Y
+9.4%
Company profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for companion animal veterinary, livestock and poultry, dairy, and water testing markets. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.
- CEO
- Jonathan J. Mazelsky
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 10,800
- Headquarters
- Maine
- Website
- idexx.com
Management & directors
- Fennell GeorgeExecutive Vice President
- Hunt NimrataExecutive Vice President
- Underberg Sharon E.EVP, GC & Corporate Secretary
- Mazelsky JayPresident and CEO
- Erickson Michael GExecutive Vice President
- Emerson AndrewEVP, CFO and Treasurer
- Johnson Michael PerkinsExecutive Vice President
- Lane MichaelExecutive Vice President
- Schreck MichaelExecutive Vice President
- Smith Martin AlexanderExecutive Vice President
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-08-04
IDXX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.1B↑ +14.3%
Diluted EPS$3.47↑ +17.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.2B | $3.4B | $3.7B | $3.9B | $4.3B |
| Gross profit | $1.6B | $1.9B | $2.0B | $2.2B | $2.4B | $2.7B |
| Operating income | $694.5M | $932.0M | $898.8M | $1.1B | $1.1B | $1.4B |
| Net income | $581.8M | $744.8M | $679.1M | $845.0M | $887.9M | $1.1B |
| Diluted EPS | $6.71 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |
| Operating cash flow | $648.1M | $755.5M | $543.0M | $906.5M | $929.0M | $1.2B |
| Free cash flow | $541.1M | $636.0M | $394.1M | $772.9M | $808.1M | $1.1B |
| Gross margin | 58.0% | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% |
| Operating margin | 25.7% | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% |
| Net margin | 21.5% | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $975.5M | $954.3M | $998.4M | $1.1B | $1.1B | $1.1B | $1.1B |
| Gross profit | $619.2M | $596.0M | $570.7M | $623.4M | $694.7M | $683.4M | $658.1M | $722.7M |
| Operating income | $263.8M | $303.9M | $261.7M | $316.5M | $373.0M | $354.8M | $315.6M | $362.6M |
| Net income | $203.3M | $232.8M | $216.1M | $242.7M | $294.0M | $274.6M | $248.2M | $278.4M |
| Diluted EPS | $2.44 | $2.80 | $2.62 | $2.96 | $3.63 | $3.40 | $3.09 | $3.47 |
| Operating cash flow | $248.3M | $220.1M | $262.0M | $238.0M | $185.7M | $402.3M | $355.8M | $266.2M |
| Free cash flow | $215.0M | $192.0M | $232.8M | $207.9M | $151.6M | $371.2M | $326.3M | $234.3M |
| Gross margin | 61.7% | 61.1% | 59.8% | 62.4% | 62.6% | 61.8% | 60.3% | 63.4% |
| Operating margin | 26.3% | 31.2% | 27.4% | 31.7% | 33.6% | 32.1% | 28.9% | 31.8% |
| Net margin | 20.3% | 23.9% | 22.7% | 24.3% | 26.5% | 24.8% | 22.8% | 24.4% |
Company news
Jul 14, 2026
Jul 9, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-01 | FENNELL GEORGE· Executive Vice President | Tax withholding | 284 | $566.79 | $160,968.36 | filing |
| 2026-06-01 | FENNELL GEORGE· Executive Vice President | Option exercise | 639 | $0.00 | $0.00 | filing |
| 2026-05-07 | SZOSTAK M ANNE | Option exercise | 257 | $0.00 | $0.00 | filing |
| 2026-05-07 | Peacock Karen | Option exercise | 101 | $0.00 | $0.00 | filing |
| 2026-05-07 | Kingsley Lawrence D | Option exercise | 257 | $0.00 | $0.00 | filing |
| 2026-05-07 | Kingsley Lawrence D | Option exercise | 82 | $0.00 | $0.00 | filing |
| 2026-05-07 | HOOLEY JOSEPH L | Option exercise | 158 | $0.00 | $0.00 | filing |
| 2026-05-07 | JUNIUS DANIEL M | Option exercise | 257 | $0.00 | $0.00 | filing |
| 2026-05-07 | Vandebroek Sophie V. | Option exercise | 257 | $0.00 | $0.00 | filing |
| 2026-04-30 | HOOLEY JOSEPH L | Award | 43 | $560.80 | $24,114.40 | filing |
| 2026-03-03 | Hunt Nimrata· Executive Vice President | Sale | 1,758 | $634.57 | $1.1M | filing |
| 2026-03-03 | Underberg Sharon E.· EVP, GC & Corporate Secretary | Option exercise | 197 | $505.53 | $99,589.41 | filing |
| 2026-02-27 | MAZELSKY JAY· President and CEO | Option exercise | 197 | $505.53 | $99,589.41 | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Option exercise | 23,326 | $141.60 | $3.3M | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 3,660 | $658.92 | $2.4M | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 2,859 | $659.75 | $1.9M | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 2,860 | $657.84 | $1.9M | filing |
| 2026-02-26 | Hunt Nimrata· Executive Vice President | Sale | 2,693 | $661.54 | $1.8M | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 2,589 | $663.04 | $1.7M | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 1,669 | $652.49 | $1.1M | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 1,488 | $655.85 | $975,904.50 | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 1,343 | $656.85 | $882,142.97 | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 1,281 | $650.67 | $833,507.63 | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 1,200 | $661.10 | $793,317.12 | filing |
| 2026-02-26 | MAZELSKY JAY· President and CEO | Sale | 1,171 | $653.68 | $765,454.95 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.